Ping‐Hui Tseng
- Immunology top 2%
- Immune Response and Inflammation 12
- interferon and immune responses 5
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 2
- Cancer Research top 2%
- NF-κB Signaling Pathways 8
- Molecular Biology top 5%
- PI3K/AKT/mTOR signaling in cancer 6
- Ubiquitin and proteasome pathways 3
- Oncology top 5%
- Cancer-related Molecular Pathways 4
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects 6
- Co-authors
- Michael KarinDario A.A. VignaliAtsushi MatsuzawaHans HäckerChing-Shih ChenHaopeng WangWeizhou ZhangSivakumar Vallabhapurapu
- Journals
- Proceedings of the National Academy of Sciences (3 papers)Scientific Reports (2 papers)International Journal of Molecular Sciences (2 papers)
- Partner nations
- TaiwanUnited StatesUnited Kingdom
In The Last Decade
Ping‐Hui Tseng
36 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 112
- Immunology 1.3k
- Cancer Research 871
- Molecular Biology 1.7k
- Oncology 512
- Pharmacology 312
Countries citing papers authored by Ping‐Hui Tseng
This map shows the geographic impact of Ping‐Hui Tseng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping‐Hui Tseng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping‐Hui Tseng more than expected).
Fields of papers citing papers by Ping‐Hui Tseng
This network shows the impact of papers produced by Ping‐Hui Tseng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping‐Hui Tseng. The network helps show where Ping‐Hui Tseng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ping‐Hui Tseng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 7 | |
| 3 | 2021 | 24 | |
| 4 | 2020 | 12 | |
| 5 | 2017 | 27 | |
| 6 | 2017 | 13 | |
| 7 | 2015 | 52 | |
| 8 | 2015 | 6 | |
| 9 | 2014 | 43 | |
| 10 | 2012 | 17 | |
| 11 | 2011 | 377 | |
| 12 | 2010 | 54 | |
| 13 | 2009 | 327 | |
| 14 | 2008 | 179 | |
| 15 | 2006 | 63 | |
| 16 | 2005 | 200 | |
| 17 | 2005 | 37 | |
| 18 | 2004 | 215 | |
| 19 | 2003 | 49 | |
| 20 | 2001 | 36 |
About Ping‐Hui Tseng
Ping‐Hui Tseng is a scholar working on Immunology, Cancer Research, Applied Microbiology and Biotechnology, Pharmacology and Oncology, having authored 36 papers that have together received 3.2k indexed citations. Recurring topics across this work include Immune Response and Inflammation (12 papers), NF-κB Signaling Pathways (8 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Inflammatory mediators and NSAID effects (6 papers), interferon and immune responses (5 papers), Cancer-related Molecular Pathways (4 papers), Ubiquitin and proteasome pathways (3 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). The work is most often cited by research in Immunology (1.3k citations), Cancer Research (871 citations), Molecular Biology (1.7k citations), Oncology (512 citations) and Pharmacology (312 citations). Ping‐Hui Tseng has collaborated with scholars based in Taiwan, United States and United Kingdom. Frequent co-authors include Michael Karin, Dario A.A. Vignali, Atsushi Matsuzawa, Hans Häcker, Ching-Shih Chen, Haopeng Wang, Weizhou Zhang, Sivakumar Vallabhapurapu, Ya-Ting Yang and Takashi Mino. Their work appears in journals such as Proceedings of the National Academy of Sciences, Scientific Reports, International Journal of Molecular Sciences, Journal of Biological Chemistry and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.